Ildong Pharmaceutical Co (XKRX:249420) ROC % : 3.14% (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Ildong Pharmaceutical Co ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Ildong Pharmaceutical Co's annualized return on capital (ROC %) for the quarter that ended in Sep. 2024 was 3.14%.

As of today (2024-12-12), Ildong Pharmaceutical Co's WACC % is 12.14%. Ildong Pharmaceutical Co's ROC % is 0.28% (calculated using TTM income statement data). Ildong Pharmaceutical Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Ildong Pharmaceutical Co ROC % Historical Data

The historical data trend for Ildong Pharmaceutical Co's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ildong Pharmaceutical Co ROC % Chart

Ildong Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROC %

Get a 7-Day Free Trial

-0.16

1.71

-6.33

-12.80

-7.25

Ildong Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROC %	Get a 7-Day Free Trial															-10.75	0.15	-0.05	1.48	3.14

Ildong Pharmaceutical Co ROC % Calculation

Ildong Pharmaceutical Co's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2023 is calculated as:

	ROC % (A: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (A: Dec. 2022 )	+	Invested Capital (A: Dec. 2023 ))	/ count )
=	-53417.577 * ( 1 - 14.12% )	/	( (634159.045	+	631216.295)	/ 2 )
=	-45875.0151276	/	632687.67
=	-7.25 %

where

	Invested Capital		(A: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	655810.214	-	55906.703	-	( 78745.854	-	max(0, 316290.402	-	282034.868	+	78745.854	))
=	634159.045

	Invested Capital		(A: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	611260.857	-	58593.2	-	( 81279.013	-	max(0, 314230.016	-	235681.378	+	81279.013	))
=	631216.295

Ildong Pharmaceutical Co's annualized Return on Capital (ROC %) for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	14480.592 * ( 1 - -27.96% )	/	( (618047.411	+	563188.749)	/ 2 )
=	18529.3655232	/	590618.08
=	3.14 %

where

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	604711.849	-	63822.799	-	( 70912.66	-	max(0, 318687.825	-	241529.464	+	70912.66	))
=	618047.411

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	590460.96	-	55346.999	-	( 61421.211	-	max(0, 284142.934	-	256068.146	+	61421.211	))
=	563188.749

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

Ildong Pharmaceutical Co (XKRX:249420) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Ildong Pharmaceutical Co's WACC % is 12.14%. Ildong Pharmaceutical Co's ROC % is 0.28% (calculated using TTM income statement data). Ildong Pharmaceutical Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Ildong Pharmaceutical Co ROC % Related Terms

Thank you for viewing the detailed overview of Ildong Pharmaceutical Co's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ildong Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ildong Pharmaceutical Co Ltd (XKRX:249420) » Definitions » ROC %

Traded in Other Exchanges

N/A

Address

2 Baumoe-ro 27-gil, Seocho-gu, Seoul, KOR, 137-733

Website

http://www.ildong.com

Ildong Pharmaceutical Co Ltd is a Korean company which is engaged in manufacturing pharmaceutical products. Its product portfolio includes generic drugs and specialty drugs, such as vitamin supplements, digestive medications, vascular medications, probiotics, topical applications, antihistamines, antipyretics, analgesics, respiratory medications, endocrine medications, psycho-neurological medications, dermatological medications, urologic medications, antibiotics and others. The company also provides raw materials such as synthesizes, probiotics and others.

Ildong Pharmaceutical Co Headlines

No Headlines